None listed
Conditions
Interventions
Drug : In the experimental group, patients will take one 75mg Pregabalin pill orally the evening before the surgery. Then, they will continue to take 75mg of Pregabalin orally twice a day for 6 weeks
Sponsors
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ?Patients aged 19 to under 70 who have been diagnosed with myofascial pain syndrome and are undergoing arthroscopic rotator cuff repair due to a tear of the rotator cuff. ?Patients with central sensitization (Central Sensitization Inventory (CSI) score of 40 or above). ?Patients who understand this study and consent to participate in it.
Exclusion criteria
Exclusion criteria: ?Patients who are not central sensitization patients (Central Sensitization Inventory (CSI) score of 40 or below) ?Patients who have previously taken Pregabalin ?Patients who exhibit hypersensitivity reactions or severe complications after taking Pregabalin. ?Patients who have been diagnosed with and are being treated for psychiatric disorders ?Patients with localized infection, sepsis, or previous neurological abnormalities ?Patients with uncontrolled hypertension, evidenced by a resting blood pressure of more than 100 mmHg ?Patients with liver function abnormalities (aspartate aminotransferase or alanine aminotransferase >60 IU/litre). ?Patients with major cardiovascular diseases or renal impairments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain VAS(Visual Analogue Scale) | — |
Secondary
| Measure | Time frame |
|---|---|
| Funcional score | — |
Countries
Korea, Republic of
Contacts
Public ContactHyungsuk Kim
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Outcome results
None listed